192 related articles for article (PubMed ID: 32581074)
1. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity.
Oh JH; Schueler KL; Stapleton DS; Alexander LM; Yen CE; Keller MP; Attie AD; van Pijkeren JP
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581074
[TBL] [Abstract][Full Text] [Related]
2. Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression.
Ting WJ; Kuo WW; Hsieh DJ; Yeh YL; Day CH; Chen YH; Chen RJ; Padma VV; Chen YH; Huang CY
Int J Mol Sci; 2015 Oct; 16(10):25881-96. PubMed ID: 26516851
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
Tenorio-Jiménez C; Martínez-Ramírez MJ; Tercero-Lozano M; Arraiza-Irigoyen C; Del Castillo-Codes I; Olza J; Plaza-Díaz J; Fontana L; Migueles JH; Olivares M; Gil Á; Gomez-Llorente C
BMC Complement Altern Med; 2018 Nov; 18(1):306. PubMed ID: 30453950
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.
Fåk F; Bäckhed F
PLoS One; 2012; 7(10):e46837. PubMed ID: 23056479
[TBL] [Abstract][Full Text] [Related]
5. Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study.
Azarang A; Farshad O; Ommati MM; Jamshidzadeh A; Heydari R; Abootalebi SN; Gholami A
Biomed Res Int; 2020; 2020():5487659. PubMed ID: 33299871
[TBL] [Abstract][Full Text] [Related]
6. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
[TBL] [Abstract][Full Text] [Related]
7.
Zheng F; Wang Z; Stanton C; Ross RP; Zhao J; Zhang H; Yang B; Chen W
Food Funct; 2021 May; 12(9):3919-3930. PubMed ID: 33977963
[TBL] [Abstract][Full Text] [Related]
8.
Tenorio-Jiménez C; Martínez-Ramírez MJ; Del Castillo-Codes I; Arraiza-Irigoyen C; Tercero-Lozano M; Camacho J; Chueca N; García F; Olza J; Plaza-Díaz J; Fontana L; Olivares M; Gil Á; Gómez-Llorente C
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31370223
[TBL] [Abstract][Full Text] [Related]
9. Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet.
Yu HR; Sheen JM; Hou CY; Lin IC; Huang LT; Tain YL; Cheng HH; Lai YJ; Lin YJ; Tiao MM; Tsai CC
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235659
[TBL] [Abstract][Full Text] [Related]
10. Heat-killed and live Lactobacillus reuteri GMNL-263 exhibit similar effects on improving metabolic functions in high-fat diet-induced obese rats.
Hsieh FC; Lan CC; Huang TY; Chen KW; Chai CY; Chen WT; Fang AH; Chen YH; Wu CS
Food Funct; 2016 May; 7(5):2374-88. PubMed ID: 27163114
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic
Espinal A; Epperly MW; Mukherjee A; Fisher R; Shields D; Wang H; Huq MS; Hamade DF; Vlad AM; Coffman L; Buckanovich R; Yu J; Leibowitz BJ; van Pijkeren JP; Patel RB; Stolz D; Watkins S; Ejaz A; Greenberger JS
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628427
[TBL] [Abstract][Full Text] [Related]
12.
Choi SI; You S; Kim S; Won G; Kang CH; Kim GH
Food Nutr Res; 2021; 65():. PubMed ID: 34776827
[TBL] [Abstract][Full Text] [Related]
13. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.
Seif El-Din SH; Salem MB; El-Lakkany NM; Hammam OA; Nasr SM; Okasha H; Ahmed LA; Saleh S; Botros SS
Hum Exp Toxicol; 2021 Sep; 40(9):1496-1509. PubMed ID: 33678036
[TBL] [Abstract][Full Text] [Related]
14. Experimental diets dictate the metabolic benefits of probiotics in obesity.
Larsen IS; Choi BS; Föh B; Kristensen NN; Ouellette A; Haller RF; Olsen PB; Saulnier D; Sina C; Jensen BAH; Marette A
Gut Microbes; 2023; 15(1):2192547. PubMed ID: 36945120
[TBL] [Abstract][Full Text] [Related]
15. High-fat-diet-induced obesity is associated with decreased antiinflammatory Lactobacillus reuteri sensitive to oxidative stress in mouse Peyer's patches.
Sun J; Qiao Y; Qi C; Jiang W; Xiao H; Shi Y; Le GW
Nutrition; 2016 Feb; 32(2):265-72. PubMed ID: 26620713
[TBL] [Abstract][Full Text] [Related]
16. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
[TBL] [Abstract][Full Text] [Related]
17. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
[TBL] [Abstract][Full Text] [Related]
18. Dual probiotic strains suppress high fructose-induced metabolic syndrome.
Park DY; Ahn YT; Huh CS; McGregor RA; Choi MS
World J Gastroenterol; 2013 Jan; 19(2):274-83. PubMed ID: 23345951
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S
Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984
[TBL] [Abstract][Full Text] [Related]
20. Combination of Probiotics and
Wang W; Xu AL; Li ZC; Li Y; Xu SF; Sang HC; Zhi F
Diabetes Metab J; 2020 Apr; 44(2):336-348. PubMed ID: 31950772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
